Market Research Logo

numares AG - Product Pipeline Analysis, 2018 Update

Summary

Numares AG (Numares), formerly Numares GmbH, is a developer and marketer of products for life science research and clinical diagnostics. The company’s AXINON lipoFIT, a test system used for lipoprotein profiling, while insightLP provides insights into lipid related research using lipoprotein composition analysis. It also offers renalTX-SCORE, a urine test that uses metabolomics for supporting the diagnosis of kidney allograft rejection. Numares’ products provide information about formation and severity of diseases, which helps doctors to make treatment decisions. The company also develops diagnostic tests for diabetes, diseases of the cardiovascular system, and for use in nephrology and in transplantation medicine. Numares is headquartered in Regensburg, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company numares AG
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


  • numares AG Company Overview
    • numares AG Company Snapshot
    • numares AG Pipeline Products and Ongoing Clinical Trials Overview
      • Table numares AG Pipeline Products and Ongoing Clinical Trials Overview
      • Table numares AG Pipeline Products by Equipment Type
      • Table Figure 1: numares AG Pipeline Products by Equipment Type
      • Table numares AG Pipeline Products by Indication
  • numares AG – Pipeline Analysis Overview
    • numares AG - Key Facts
      • Table numares AG, Key Facts
    • numares AG - Major Products and Services
      • Table numares AG, Major Products and Services
    • numares AG Pipeline Products by Development Stage
      • Table Figure 2: numares AG Pipeline Products by Development Stage
      • Table numares AG Number of Pipeline Products by Development Stage
      • Table numares AG Pipeline Products Summary by Development Stage
    • numares AG Ongoing Clinical Trials by Trial Status
      • Table Figure 3: numares AG Ongoing Clinical Trials by Trial Status
      • Table numares AG Ongoing Clinical Trials by Trial Status
      • Table numares AG Ongoing Clinical Trials Summary
  • numares AG Pipeline Products Overview
    • AXINON - Multiple Sclerosis
      • AXINON - Multiple Sclerosis Product Overview
        • Table AXINON - Multiple Sclerosis - Product Status
        • Table AXINON - Multiple Sclerosis - Product Description
    • AXINON lipoFIT-S100
      • AXINON lipoFIT-S100 Product Overview
        • Table AXINON lipoFIT-S100 - Product Status
        • Table AXINON lipoFIT-S100 - Product Description
    • AXINON lipoFIT-S100-400
      • AXINON lipoFIT-S100-400 Product Overview
        • Table AXINON lipoFIT-S100-400 - Product Status
        • Table AXINON lipoFIT-S100-400 - Product Description
    • AXINON Test - Bladder Cancer
      • AXINON Test - Bladder Cancer Product Overview
        • Table AXINON Test - Bladder Cancer - Product Status
        • Table AXINON Test - Bladder Cancer - Product Description
      • AXINON Test - Bladder Cancer Clinical Trial
        • Table AXINON Test - Bladder Cancer - Bladder Cancer Detection Using Metabolomic Evaluation of Urine and Blood
    • AXINON Test - Coronary Heart Disease
      • AXINON Test - Coronary Heart Disease Product Overview
        • Table AXINON Test - Coronary Heart Disease - Product Status
        • Table AXINON Test - Coronary Heart Disease - Product Description
    • AXINON Test - Prostate Cancer
      • AXINON Test - Prostate Cancer Product Overview
        • Table AXINON Test - Prostate Cancer - Product Status
        • Table AXINON Test - Prostate Cancer - Product Description
    • AXINON Test - Renal Insufficiency
      • AXINON Test - Renal Insufficiency Product Overview
        • Table AXINON Test - Renal Insufficiency - Product Status
        • Table AXINON Test - Renal Insufficiency - Product Description
      • AXINON Test - Renal Insufficiency Clinical Trial
        • Table AXINON Test - Renal Insufficiency - An European Multi-center Study on Clinical Use of AXINON renalTX-SCORE in Diagnosis of Kidney Allograft Rejection
    • AXINON Test - Urothelial Cancer
      • AXINON Test - Urothelial Cancer Product Overview
        • Table AXINON Test - Urothelial Cancer - Product Status
        • Table AXINON Test - Urothelial Cancer - Product Description
    • Diagnostic Test - Diabetes
      • Diagnostic Test - Diabetes Product Overview
        • Table Diagnostic Test - Diabetes - Product Status
        • Table Diagnostic Test - Diabetes - Product Description
    • renalTX-SCORE
      • renalTX-SCORE Product Overview
        • Table renalTX-SCORE - Product Status
        • Table renalTX-SCORE - Product Description
      • renalTX-SCORE Clinical Trial
        • Table renalTX-SCORE - An European Multi-center Study on Clinical Use of AXINON renalTX-SCORE in Diagnosis of Kidney Allograft Rejection
  • numares AG - Key Competitors
  • numares AG - Key Employees
    • Table numares AG, Key Employees
  • numares AG - Locations And Subsidiaries
    • Head Office
  • Recent Developments
    • numares AG, Recent Developments
      • May 18, 2018: numares initiates pan-European multicenter study of AXINON renalTX-SCORE on kidney allograft rejection
      • Jul 13, 2017: numares Achieves Key Milestone: Identifies Candidate Metabolomic Network for Bladder Cancer Diagnostics
      • Apr 04, 2017: numares announces commercial launch of renalTX-SCORE
      • Mar 23, 2017: numares and Oxford University to collaborate on development of Multiple Sclerosis diagnostic test
      • Feb 07, 2017: numares Initiates Worldwide Commercial Launch of insightLP-S50 to Provide New Insights in Lipoprotein Research
      • Dec 08, 2016: numares Opens Singapore Subsidiary to Expand Its Diagnostic System into Asia
      • Aug 10, 2016: Numares appoints Dr. Titus Kaletta as executive board member
      • Nov 04, 2015: Kidney rejection after transplantation: numares develops radically new urinalysis procedure
      • Mar 26, 2015: numares technology offers performance and robustness: 500,000 lipoprotein tests in US laboratory
      • Mar 04, 2015: numares announces lipoFIT-S100 market launch
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report